We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

89 hedge funds and large institutions have $369M invested in Theravance Biopharma in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more call options, than puts

Call options by funds: $94K | Put options by funds: $28K

15% more capital invested

Capital invested by funds: $320M → $369M (+$48.6M)

10% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 29

4% less funds holding

Funds holding: 93 → 89 (-4)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

Holders
89
Holders Change
-4
Holders Change %
-4.3%
% of All Funds
2.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
32
Reduced
29
Closed
15
Calls
$94K
Puts
$28K
Net Calls
+$66K
Net Calls Change
-$172K

Top Buyers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
+$12.2M
2
AC
Armistice Capital
New York
+$9.39M
3
BG
Baupost Group
Massachusetts
+$5.6M
4
BFA
BlackRock Fund Advisors
California
+$5.5M
5
UBS AM
UBS AM
Illinois
+$4.36M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$9.94M
2
FAM
Foundation Asset Management
New York
-$6.42M
3
Deutsche Bank
Deutsche Bank
Germany
-$4.74M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.01M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$2.01M +$55.7K +3,039 +3%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$1.73M – – –
TCIM
28
TIAA CREF Investment Management
New York
$1.46M – – –
Bank of America
29
Bank of America
North Carolina
$1.42M -$297K -16,220 -17%
BIM
30
BlackRock Investment Management
Delaware
$1.2M +$10.7K +583 +0.9%
Charles Schwab
31
Charles Schwab
California
$1.16M +$58K +3,162 +5%
RP
32
Reinhart Partners
Wisconsin
$1.16M -$96.1K -5,240 -7%
NI
33
Numeric Investors
Massachusetts
$989K +$572K +31,215 +121%
Millennium Management
34
Millennium Management
New York
$876K -$1.79M -97,853 -66%
Macquarie Group
35
Macquarie Group
Australia
$868K -$505K -27,548 -36%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$745K -$12.8K -700 -2%
PAM
37
Panagora Asset Management
Massachusetts
$741K +$255K +13,888 +48%
RC
38
Roundview Capital
New Jersey
$705K -$23.6K -1,290 -3%
Citadel Advisors
39
Citadel Advisors
Florida
$662K -$183K -9,981 -21%
ARC
40
Absolute Return Capital
Massachusetts
$592K -$528K -28,790 -46%
TA
41
Teachers Advisors
New York
$571K – – –
ProShare Advisors
42
ProShare Advisors
Maryland
$529K +$75.5K +4,117 +16%
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$505K -$495 -27 -0.1%
BAMS
44
Bellevue Asset Management (Switzerland)
Switzerland
$484K +$511K +27,891 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$454K – – –
BG
46
BlackRock Group
United Kingdom
$451K +$17K +930 +4%
Fidelity Investments
47
Fidelity Investments
Massachusetts
$426K – – –
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$414K – – –
HCM
49
Highbridge Capital Management
New York
$409K -$627K -34,205 -59%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$399K +$50.9K +2,775 +14%
1
2
3 4 5

TBPH Hedge Fund Activity: Q1 2015 in Review

89 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q1 2015, worth a combined $369M — up 15% from $320M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of TBPH and 12 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 32 added.

The largest buyer was Norges Bank, adding an estimated $12.2M. The largest seller was Capital World Investors, cutting an estimated $9.94M.

  • 89 institutional investors held Theravance Biopharma (TBPH) as of Q1 2015, down from 93 in Q4 2014.
  • Funds reported $369M of Theravance Biopharma stock for Q1 2015, up 15% quarter-over-quarter.
  • 12 funds opened new Theravance Biopharma positions in Q1 2015 and 15 closed out, a net change of -3 holders.
  • The largest Theravance Biopharma buyer in Q1 2015 was Norges Bank, an estimated $12.2M added.
  • The largest Theravance Biopharma seller in Q1 2015 was Capital World Investors, an estimated $9.94M sold.

Based on aggregated 13F filings for Q1 2015.